Following the discoveries that a wellness product the company sells may be linked to 80 deaths, best Kobayashi Pharmaceutical professionals resigned on Tuesday. Both Kazumasa Kobayashi, the agency’s founder, and leader Akihiro Kobayashi, both have family roots.
The controversy revolves around over-the-counter capsules meant to reduce cholesterol. A troubling physical investigation funded by the business revealed that command had ignored consumer safety risks with an “insufficient sense of urgency.”
Red yeast rice or “beni koji,” which has been fermented with mildew nations, is used to make the pills in query. While a staple ingredient in eastern Asiatic food and drink for ages, it has a history of causing tissue injury based on its chemical makeup.
Company acted very gently, audit finds
In March, many shoppers reported having kidney problems as their first concern. A federal investigation was launched in response to the revelations that mold was creating a potentially harmful acid at one of its factories.
The government at the time criticized Kobayashi for not making a report on the number of cases being looked into as “extremely tragic.”
Kobayashi is a family name in Japan, a country with a reputation for great consumer protections.
The company was criticized in an additional report released on Tuesday, which claimed it had “never before received many reports of severe cases from specialists in such short period of time.”
The business should possess instantly recalled the goods and reported the incident, but it only made that decision after an internal investigation, according to the audit attorneys.
